Marketing-authorisation holder · United States
Shilpa
2 medicines in 1 country, as authorisation holder.
Group structure
Part of
ShilpaPharmaceutical groupOther companies in the group
Headquarters not stated2
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
2 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BORTEZOMIB3.5mg/1.4ml (2.5mg/ml) · Solution | Bortezomib | United States | Marketed | 2024 |
| PEMETREXED100mg/10ml base (10mg/ml) | 1gm/100ml base (10mg/ml) | 500mg/50ml base (10mg/ml) · Solution | Pemetrexed | United States | Marketed | 2023 |